Compound Detail
CHEMBL3112866
SAR-260301 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL3112866 |
| Name | SAR-260301 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | UAXHPOBBKRWJGA-ZDUSSCGKSA-N |
10
Targets
18
Activities
2
Assay Types
30
PK Parameters
20
Publications
2
Known Names
1
Indications
1
Mechanisms
Molecular Properties
354.4
MW (Da)
1.13
ALogP
5
HBA
1
HBD
78.5
PSA (Ų)
0.89
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| PI3-kinase p110-beta subunit inhibitor | INHIBITOR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
IC50 16 meas. best 7.8
EC50 2 meas. best 6.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| RAC-alpha serine/threonine-protein kinase CHEMBL4282 | IC50 | 7.8 | 7.6967 | 16.0 | 6 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform CHEMBL3145 | IC50 | 7.64 | 7.39 | 23.0 | 3 |
| Phosphatidylinositol 3-kinase catalytic subunit type 3 CHEMBL1075165 | IC50 | 6.74 | 6.74 | 183.0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform CHEMBL3130 | IC50 | 6.33 | 6.33 | 468.0 | 1 |
| Mus musculus CHEMBL375 | EC50 | 6.17 | 5.755 | 680.0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform CHEMBL4005 | IC50 | 5.81 | 5.81 | 1539.0 | 1 |
| DNA-dependent protein kinase catalytic subunit CHEMBL3142 | IC50 | 5.7 | 5.7 | 2000.0 | 1 |
| Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma CHEMBL1163120 | IC50 | 5.42 | 5.42 | 3812.0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform CHEMBL3267 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.4 | 4.4 | 40000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 14000.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 6580.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 2410.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 864.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 11000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 610.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 600.0 | ng.hr.mL-1 | Mus musculus |
| CL | 6.667 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 56.67 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 83.33 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 13458.99 | nM | Canis lupus familiaris |
| Cmax | 13882.23 | nM | Canis lupus familiaris |
| Cmax | 4119.52 | nM | Rattus norvegicus |
| Cmax | 3385.91 | nM | Rattus norvegicus |
| Cmax | 25281.45 | nM | Mus musculus |
| Cmax | 2392.71 | nM | Mus musculus |
| Cmax | 5276.37 | nM | Mus musculus |
| F | 67.0 | % | Canis lupus familiaris |
| F | 70.0 | % | Rattus norvegicus |
| F | 55.0 | % | Mus musculus |
| F | 30.0 | % | Mus musculus |
| Fu | 0.4 | - | Mus musculus |
| T1/2 | 4.5 | hr | Canis lupus familiaris |
| T1/2 | 5.0 | hr | Canis lupus familiaris |
| T1/2 | 6.9 | hr | Rattus norvegicus |
| T1/2 | 0.87 | hr | Rattus norvegicus |
| T1/2 | 2.5 | hr | Mus musculus |
| T1/2 | 1.4 | hr | Mus musculus |
| T1/2 | 0.87 | hr | Mus musculus |
| Tmax | 0.5 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24387221 | 10.1021/jm401642q | Mus musculus | 24 |
| 24387221 | 10.1021/jm401642q | Canis familiaris | 11 |
| 24387221 | 10.1021/jm401642q | Rattus norvegicus | 10 |
| 24387221 | 10.1021/jm401642q | Plasma | 8 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 5 |
| 24387221 | 10.1021/jm401642q | Liver microsome | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 24387221 | 10.1021/jm401642q | Caco-2 | 2 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 3-kinase catalytic subunit type 3 | 1 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma | 1 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 1 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 1 |
| 24387221 | 10.1021/jm401642q | DNA-dependent protein kinase catalytic subunit | 1 |
| 24387221 | 10.1021/jm401642q | Serine/threonine-protein kinase mTOR | 1 |
| 24387221 | 10.1021/jm401642q | Cytochrome P450 3A4 | 1 |
| 24387221 | 10.1021/jm401642q | ADMET | 1 |
| 24387221 | 10.1021/jm401642q | PC-3 | 1 |
| 24387221 | 10.1021/jm401642q | No relevant target | 1 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 1 |
| 24387221 | 10.1021/jm401642q | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 1 |
Data from ChEMBL 36 via Core Engine